Eden Biodesign, the operator of the UK National Biomanufacturing Centre (NBC), and Onyvax Limited, the biotechnology company developing novel cancer therapies, today announced a commercial agreement where Eden will supply cGMP clinical manufacturing services to Onyvax for its Cell Vaccine program in ovarian cancer.
